VCM
ZOM

Vivaldi Capital Management’s Zomedica Corp. ZOM Stock Holding History

Vivaldi Capital Management’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-12,300
Closed -$1.51K – 297
2024
Q4 		$1.51K Buy
+12,300
New +$1.55K ﹤0.01% 287

Other funds holding ZOM

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
PRTG
Post Resch Tallon Group Pittsford, New York $145M AUM 25.19% 1-Year Est. Return
JWM
Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return
GJIA
Glass Jacobson Investment Advisors Owings Mills, Maryland $290M AUM 17.7% 1-Year Est. Return
PCIA
Prime Capital Investment Advisors Overland Park, Kansas $8.65B AUM 19.52% 1-Year Est. Return

Vivaldi Capital Management's ZOM Position: Q1 2025 in Review

Vivaldi Capital Management sold out of Zomedica Corp. (ZOM) in Q1 2025, closing a stake of 12,300 shares — an estimated $1.51K sold.

Vivaldi Capital Management first reported a position in ZOM in Q4 2024 and held it in 1 quarter. The position peaked at $1.51K in Q4 2024. 23 funds tracked by Wall St. Rank hold ZOM as of Q1 2025.

  • Vivaldi Capital Management reported no remaining Zomedica Corp. position as of Q1 2025 after selling out during the quarter.
  • Vivaldi Capital Management sold 12,300 Zomedica Corp. shares in Q1 2025, an estimated $1.51K.
  • Vivaldi Capital Management first reported a position in Zomedica Corp. in Q4 2024 and held it in 1 quarter.
  • Vivaldi Capital Management's Zomedica Corp. position peaked at $1.51K in Q4 2024.
  • 23 funds tracked by Wall St. Rank held Zomedica Corp. as of Q1 2025.

Based on Vivaldi Capital Management's 13F filing for Q1 2025, filed 15 May 2025.